alfacalcidol
Selected indexed studies
- Alfacalcidol versus plain vitamin D in inflammation induced bone loss. (J Rheumatol Suppl, 2005) [PMID:16142848]
- [Utilization of alfacalcidol and active vitamin D analogs in chronic kidney disease]. (Nephrol Ther, 2018) [PMID:29545131]
- Alfacalcidol-Induced Kidney Injury in Patients with Severe Motor and Intellectual Disabilities. (J Nutr Sci Vitaminol (Tokyo), 2024) [PMID:39477472]
_Worker-drafted node — pending editorial review._
Connections
alfacalcidol is a side effect of
Sources
- Alfacalcidol versus plain vitamin D in inflammation induced bone loss. (2005) pubmed
- [Utilization of alfacalcidol and active vitamin D analogs in chronic kidney disease]. (2018) pubmed
- Alfacalcidol-Induced Kidney Injury in Patients with Severe Motor and Intellectual Disabilities. (2024) pubmed
- Alfacalcidol and calcitriol in the prevention of bone loss after organ transplantation. (1999) pubmed
- Alfacalcidol vs Calcitriol in the Management of Patient With Hypoparathyroidism: A Randomized Controlled Trial. (2021) pubmed
- D-hormone analog alfacalcidol: an update on its role in post-menopausal osteoporosis and rheumatoid arthritis management. (2005) pubmed
- Alfacalcidol and hypercalcaemia. (1987) pubmed
- Effects of alfacalcidol on cardiovascular outcomes according to alkaline phosphatase levels in the J-DAVID trial. (2022) pubmed
- Alfacalcidol enhances collagen quality in ovariectomized rat bones. (2014) pubmed
- Is there a differential response to alfacalcidol and vitamin D in the treatment of osteoporosis? (1997) pubmed